cleveland clinic l-carnitine study γ-Butyrobetaine Is a Proatherogenic Intermediate in Gut Microbial Metabolism of to TMAO: Cell Metabolism Your gut may be affecting
Your gut may be affecting your heartbeat. Cleveland Clinic researchers found a new link between a gut bacteria byproduct called TMAO and a higher risk for atrial fibrillation. TMAO is produced by Cleveland Clinic Researchers First to Show Dietary Choline and Gut Bacteria Byproduct Linked with Increased Blood Clotting Risk, Heart Disease Butyrobetaine is a pro atherogenic intermediate in gut microbial metabolism of L carnitine to TMAO PMC Cleveland Clinic Studies Reveal Role of Red Meat in Gut Bacteria, Heart Disease Development
Pay in 4 interest-free payments of $5.47 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
